Pakistan

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
2.3 (2.04 - 2.61) 2019 Modelled IHME
2.31 (2.05 - 2.61) 2018 Modelled IHME
2.34 (2.05 - 2.66) 2017 Modelled IHME
2.48 (2.18 - 2.80) 2016 Modelled IHME
2.61 (2.30 - 2.93) 2015 Modelled IHME
2.58 (2.29 - 2.88) 2014 Modelled IHME
2.52 (2.27 - 2.79) 2013 Modelled IHME
2.45 (2.23 - 2.69) 2012 Modelled IHME
2.38 (2.19 - 2.61) 2011 Modelled IHME
2.36 (2.17 - 2.57) 2010 Modelled IHME
2.37 (2.18 - 2.57) 2009 Modelled IHME
2.39 (2.21 - 2.59) 2008 Modelled IHME
2.42 (2.24 - 2.62) 2007 Modelled IHME
2.46 (2.27 - 2.66) 2006 Modelled IHME
2.5 (2.31 - 2.70) 2005 Modelled IHME
2.55 (2.36 - 2.75) 2004 Modelled IHME
2.61 (2.40 - 2.83) 2003 Modelled IHME
2.68 (2.46 - 2.91) 2002 Modelled IHME
2.75 (2.52 - 3.01) 2001 Modelled IHME
2.84 (2.58 - 3.12) 2000 Modelled IHME
2.95 (2.68 - 3.25) 1999 Modelled IHME
3.08 (2.81 - 3.39) 1998 Modelled IHME
3.22 (2.93 - 3.54) 1997 Modelled IHME
3.35 (3.02 - 3.69) 1996 Modelled IHME
3.44 (3.08 - 3.81) 1995 Modelled IHME
3.51 (3.11 - 3.93) 1994 Modelled IHME
3.57 (3.13 - 4.03) 1993 Modelled IHME
3.63 (3.15 - 4.12) 1992 Modelled IHME
3.67 (3.16 - 4.21) 1991 Modelled IHME
3.7 (3.15 - 4.30) 1990 Modelled IHME
5.63 (4.44 - 7.31) 2015 Modelled WHO
2.1 (2 - 3.30) 2016 Modelled Razavi-Shearer et al, 2018
2.76 (2.73 - 2.79) 2013 Modelled Schweitzer et al, 2015
2.5 2010 Survey/reported Qureshi et al, 2010
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.54 (0.43 - 0.68) 2019 Modelled IHME
0.57 (0.45 - 0.71) 2018 Modelled IHME
0.6 (0.48 - 0.75) 2017 Modelled IHME
0.64 (0.51 - 0.79) 2016 Modelled IHME
0.67 (0.54 - 0.83) 2015 Modelled IHME
0.68 (0.55 - 0.83) 2014 Modelled IHME
0.69 (0.56 - 0.83) 2013 Modelled IHME
0.69 (0.57 - 0.83) 2012 Modelled IHME
0.7 (0.57 - 0.83) 2011 Modelled IHME
0.7 (0.58 - 0.83) 2010 Modelled IHME
0.71 (0.58 - 0.84) 2009 Modelled IHME
0.71 (0.59 - 0.84) 2008 Modelled IHME
0.72 (0.60 - 0.85) 2007 Modelled IHME
0.73 (0.60 - 0.86) 2006 Modelled IHME
0.74 (0.62 - 0.87) 2005 Modelled IHME
0.85 (0.71 - 1) 2004 Modelled IHME
1.12 (0.92 - 1.31) 2003 Modelled IHME
1.44 (1.18 - 1.69) 2002 Modelled IHME
1.73 (1.42 - 2.04) 2001 Modelled IHME
1.91 (1.57 - 2.27) 2000 Modelled IHME
2.01 (1.64 - 2.39) 1999 Modelled IHME
2.08 (1.71 - 2.50) 1998 Modelled IHME
2.15 (1.77 - 2.58) 1997 Modelled IHME
2.2 (1.80 - 2.66) 1996 Modelled IHME
2.23 (1.81 - 2.72) 1995 Modelled IHME
2.26 (1.82 - 2.77) 1994 Modelled IHME
2.28 (1.81 - 2.82) 1993 Modelled IHME
2.3 (1.82 - 2.86) 1992 Modelled IHME
2.32 (1.82 - 2.90) 1991 Modelled IHME
2.33 (1.81 - 2.96) 1990 Modelled IHME
2.75 (2.02 - 3.67) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
4,171,710 (3,558,800 - 4,846,440) 1990 Modelled IHME
4,234,710 (3,646,690 - 4,859,340) 1991 Modelled IHME
4,281,040 (3,718,690 - 4,861,930) 1992 Modelled IHME
4,313,350 (3,776,650 - 4,860,730) 1993 Modelled IHME
4,334,610 (3,835,120 - 4,855,760) 1994 Modelled IHME
4,348,030 (3,889,370 - 4,815,740) 1995 Modelled IHME
4,327,710 (3,904,830 - 4,766,560) 1996 Modelled IHME
4,260,630 (3,867,260 - 4,684,680) 1997 Modelled IHME
4,171,380 (3,801,100 - 4,585,960) 1998 Modelled IHME
4,086,900 (3,715,540 - 4,501,230) 1999 Modelled IHME
4,036,180 (3,663,590 - 4,439,350) 2000 Modelled IHME
4,014,950 (3,672,820 - 4,394,270) 2001 Modelled IHME
4,000,200 (3,675,710 - 4,358,230) 2002 Modelled IHME
3,995,520 (3,687,300 - 4,339,680) 2003 Modelled IHME
4,005,010 (3,706,720 - 4,333,430) 2004 Modelled IHME
4,032,280 (3,732,890 - 4,355,180) 2005 Modelled IHME
4,069,410 (3,764,670 - 4,400,700) 2006 Modelled IHME
4,109,650 (3,798,770 - 4,451,620) 2007 Modelled IHME
4,158,850 (3,842,360 - 4,512,170) 2008 Modelled IHME
4,224,410 (3,892,410 - 4,593,480) 2009 Modelled IHME
4,314,540 (3,965,620 - 4,695,770) 2010 Modelled IHME
4,469,290 (4,104,000 - 4,889,530) 2011 Modelled IHME
4,696,520 (4,274,710 - 5,163,820) 2012 Modelled IHME
4,953,520 (4,453,840 - 5,484,720) 2013 Modelled IHME
5,193,350 (4,605,970 - 5,793,680) 2014 Modelled IHME
5,364,760 (4,728,230 - 6,034,320) 2015 Modelled IHME
5,212,860 (4,582,100 - 5,887,100) 2016 Modelled IHME
5,018,070 (4,396,320 - 5,713,410) 2017 Modelled IHME
5,073,500 (4,497,760 - 5,730,560) 2018 Modelled IHME
5,161,400 (4,570,900 - 5,838,200) 2019 Modelled IHME
3,962,000 (3,906,000 - 6,364,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
7.23 (5.30 - 9.67) 2019 Modelled IHME
7.26 (5.25 - 9.75) 2018 Modelled IHME
7.3 (5.27 - 9.76) 2017 Modelled IHME
7.25 (5.28 - 9.58) 2016 Modelled IHME
7.26 (5.25 - 9.54) 2015 Modelled IHME
7.33 (5.45 - 9.62) 2014 Modelled IHME
7.38 (5.43 - 9.64) 2013 Modelled IHME
7.4 (5.50 - 9.68) 2012 Modelled IHME
7.48 (5.35 - 9.72) 2011 Modelled IHME
7.57 (5.54 - 9.79) 2010 Modelled IHME
7.63 (5.58 - 9.82) 2009 Modelled IHME
7.67 (5.75 - 9.81) 2008 Modelled IHME
7.7 (5.73 - 9.85) 2007 Modelled IHME
7.79 (5.83 - 9.85) 2006 Modelled IHME
7.89 (6.04 - 9.93) 2005 Modelled IHME
8 (6.05 - 10) 2004 Modelled IHME
8.13 (6.11 - 10.20) 2003 Modelled IHME
8.27 (6.17 - 10.40) 2002 Modelled IHME
8.37 (6.22 - 10.60) 2001 Modelled IHME
8.4 (6.13 - 10.80) 2000 Modelled IHME
8.39 (6.17 - 10.70) 1999 Modelled IHME
8.46 (6.19 - 10.80) 1998 Modelled IHME
8.6 (6.19 - 11) 1997 Modelled IHME
8.67 (6.06 - 11.20) 1996 Modelled IHME
8.69 (6.06 - 11.50) 1995 Modelled IHME
8.6 (5.87 - 11.60) 1994 Modelled IHME
8.57 (5.64 - 11.60) 1993 Modelled IHME
8.59 (5.59 - 11.80) 1992 Modelled IHME
8.57 (5.48 - 12.10) 1991 Modelled IHME
8.56 (5.41 - 12.20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
16,208 (11,878 - 21,656) 2019 Modelled IHME
15,916 (11,508 - 21,399) 2018 Modelled IHME
15,686 (11,324 - 20,956) 2017 Modelled IHME
15,249 (11,104 - 20,149) 2016 Modelled IHME
14,927 (10,797 - 19,620) 2015 Modelled IHME
14,749 (10,970 - 19,338) 2014 Modelled IHME
14,515 (10,671 - 18,946) 2013 Modelled IHME
14,209 (10,556 - 18,591) 2012 Modelled IHME
14,023 (10,034 - 18,218) 2011 Modelled IHME
13,860 (10,135 - 17,916) 2010 Modelled IHME
13,622 (9,966 - 17,526) 2009 Modelled IHME
13,359 (10,008 - 17,093) 2008 Modelled IHME
13,074 (9,734 - 16,719) 2007 Modelled IHME
12,898 (9,656 - 16,298) 2006 Modelled IHME
12,732 (9,747 - 16,025) 2005 Modelled IHME
12,584 (9,524 - 15,756) 2004 Modelled IHME
12,465 (9,378 - 15,639) 2003 Modelled IHME
12,370 (9,232 - 15,624) 2002 Modelled IHME
12,201 (9,063 - 15,388) 2001 Modelled IHME
11,948 (8,715 - 15,402) 2000 Modelled IHME
11,638 (8,562 - 14,813) 1999 Modelled IHME
11,459 (8,383 - 14,627) 1998 Modelled IHME
11,372 (8,182 - 14,594) 1997 Modelled IHME
11,202 (7,830 - 14,491) 1996 Modelled IHME
10,973 (7,655 - 14,565) 1995 Modelled IHME
10,612 (7,238 - 14,262) 1994 Modelled IHME
10,342 (6,811 - 14,010) 1993 Modelled IHME
10,135 (6,599 - 13,963) 1992 Modelled IHME
9,894 (6,329 - 13,986) 1991 Modelled IHME
9,657 (6,100 - 13,729) 1990 Modelled IHME
15,531 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
18 (15 - 21) 2019 Modelled IHME
18 (15 - 21) 2018 Modelled IHME
18 (14 - 21) 2017 Modelled IHME
18 (15 - 21) 2016 Modelled IHME
18 (15 - 21) 2015 Modelled IHME
18 (15 - 21) 2014 Modelled IHME
18 (15 - 21) 2013 Modelled IHME
18 (15 - 21) 2012 Modelled IHME
18 (15 - 21) 2011 Modelled IHME
18 (15 - 21) 2010 Modelled IHME
18 (15 - 21) 2009 Modelled IHME
18 (15 - 21) 2008 Modelled IHME
18 (15 - 21) 2007 Modelled IHME
17 (15 - 21) 2006 Modelled IHME
17 (15 - 21) 2005 Modelled IHME
17 (15 - 21) 2004 Modelled IHME
17 (14 - 21) 2003 Modelled IHME
17 (14 - 20) 2002 Modelled IHME
17 (14 - 21) 2001 Modelled IHME
17 (14 - 20) 2000 Modelled IHME
17 (14 - 20) 1999 Modelled IHME
17 (14 - 20) 1998 Modelled IHME
17 (14 - 20) 1997 Modelled IHME
17 (14 - 20) 1996 Modelled IHME
16 (14 - 20) 1995 Modelled IHME
16 (13 - 19) 1994 Modelled IHME
16 (13 - 19) 1993 Modelled IHME
16 (13 - 19) 1992 Modelled IHME
16 (13 - 19) 1991 Modelled IHME
16 (13 - 19) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
75 2018 Survey/reported WHO/UNICEF
75 2017 Survey/reported WHO/UNICEF
75 2016 Survey/reported WHO/UNICEF
72 2015 Survey/reported WHO/UNICEF
69 2014 Survey/reported WHO/UNICEF
65 2013 Survey/reported WHO/UNICEF
64 2012 Survey/reported WHO/UNICEF
63 2011 Survey/reported WHO/UNICEF
52 2010 Survey/reported WHO/UNICEF
52 2009 Survey/reported WHO/UNICEF
53 2008 Survey/reported WHO/UNICEF
54 2007 Survey/reported WHO/UNICEF
60 2006 Survey/reported WHO/UNICEF
65 2005 Survey/reported WHO/UNICEF
62 2004 Survey/reported WHO/UNICEF
62 2003 Survey/reported WHO/UNICEF
75 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
18 (16 - 21) 2015 Survey/reported Pakistan National AIDS Control Program, 2015
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2015 Survey/reported NACP, 2015.
HBV National Action Plan
Source:
HBV elimination goal
Source:
Year of HBV elimination goal
2030
Source:
HBV testing policy
Pregnant women
Source:
HepB birth dose policy
Yes
Source:
Eligible for HBV generic medicines
Source: MPP
Year of birth dose introduction
2016
Source: WHO
HCV National Action Plan
Source:
HCV elimination goal
Source:
Year of HCV elimination goal
2030
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.68 (1.34 - 2.09) 2019 Modelled IHME
1.69 (1.34 - 2.09) 2018 Modelled IHME
1.69 (1.35 - 2.09) 2017 Modelled IHME
1.9 (1.53 - 2.36) 2016 Modelled IHME
2.16 (1.75 - 2.68) 2015 Modelled IHME
2.27 (1.83 - 2.82) 2014 Modelled IHME
2.36 (1.91 - 2.92) 2013 Modelled IHME
2.43 (1.96 - 3.01) 2012 Modelled IHME
2.48 (2 - 3.07) 2011 Modelled IHME
2.5 (2.01 - 3.09) 2010 Modelled IHME
2.5 (2.01 - 3.09) 2009 Modelled IHME
2.49 (2.01 - 3.07) 2008 Modelled IHME
2.48 (2 - 3.06) 2007 Modelled IHME
2.47 (1.99 - 3.04) 2006 Modelled IHME
2.46 (1.98 - 3.02) 2005 Modelled IHME
2.39 (1.93 - 2.96) 2004 Modelled IHME
2.27 (1.84 - 2.80) 2003 Modelled IHME
2.13 (1.72 - 2.62) 2002 Modelled IHME
2.02 (1.63 - 2.49) 2001 Modelled IHME
1.97 (1.59 - 2.44) 2000 Modelled IHME
1.99 (1.60 - 2.45) 1999 Modelled IHME
2.02 (1.62 - 2.48) 1998 Modelled IHME
2.06 (1.65 - 2.53) 1997 Modelled IHME
2.09 (1.68 - 2.58) 1996 Modelled IHME
2.11 (1.68 - 2.60) 1995 Modelled IHME
2.1 (1.69 - 2.59) 1994 Modelled IHME
2.1 (1.68 - 2.59) 1993 Modelled IHME
2.09 (1.67 - 2.59) 1992 Modelled IHME
2.06 (1.65 - 2.58) 1991 Modelled IHME
2.04 (1.63 - 2.55) 1990 Modelled IHME
3.8 (2.80 - 3.90) 2015 Modelled Blach et al, 2017
5.8 (1.40 - 8.70) 2014 Modelled Gower et al, 2014
Showing out of
Show more
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
6.7 (1.60 - 10) 2014 Modelled Gower et al, 2014
4.8 2010 Survey/reported Qureshi et al, 2010
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
36.5 (0 - 79.10) 2013 Modelled Degenhardt L et al, 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
2,296,440 (1,837,780 - 2,879,210) 1990 Modelled IHME
2,382,570 (1,906,760 - 2,974,290) 1991 Modelled IHME
2,460,490 (1,968,470 - 3,054,960) 1992 Modelled IHME
2,531,480 (2,028,830 - 3,129,000) 1993 Modelled IHME
2,597,020 (2,081,780 - 3,197,950) 1994 Modelled IHME
2,658,730 (2,124,940 - 3,276,080) 1995 Modelled IHME
2,702,280 (2,163,840 - 3,337,740) 1996 Modelled IHME
2,722,000 (2,185,740 - 3,349,360) 1997 Modelled IHME
2,733,700 (2,199,120 - 3,363,000) 1998 Modelled IHME
2,754,760 (2,215,310 - 3,399,270) 1999 Modelled IHME
2,803,840 (2,258,200 - 3,463,370) 2000 Modelled IHME
2,944,570 (2,373,760 - 3,628,350) 2001 Modelled IHME
3,191,680 (2,569,210 - 3,922,550) 2002 Modelled IHME
3,487,540 (2,814,590 - 4,295,300) 2003 Modelled IHME
3,768,300 (3,042,760 - 4,650,720) 2004 Modelled IHME
3,962,380 (3,195,820 - 4,866,450) 2005 Modelled IHME
4,087,980 (3,294,130 - 5,037,820) 2006 Modelled IHME
4,213,500 (3,395,510 - 5,194,500) 2007 Modelled IHME
4,336,800 (3,492,500 - 5,350,300) 2008 Modelled IHME
4,456,480 (3,582,670 - 5,515,400) 2009 Modelled IHME
4,571,090 (3,669,760 - 5,663,070) 2010 Modelled IHME
4,652,200 (3,747,000 - 5,754,320) 2011 Modelled IHME
4,675,290 (3,765,490 - 5,780,790) 2012 Modelled IHME
4,645,390 (3,747,540 - 5,740,640) 2013 Modelled IHME
4,568,540 (3,689,300 - 5,665,190) 2014 Modelled IHME
4,451,800 (3,595,980 - 5,521,580) 2015 Modelled IHME
3,992,790 (3,214,200 - 4,952,200) 2016 Modelled IHME
3,626,650 (2,900,230 - 4,497,330) 2017 Modelled IHME
3,697,200 (2,948,190 - 4,577,980) 2018 Modelled IHME
3,774,440 (2,999,760 - 4,679,890) 2019 Modelled IHME
7,172,000 (5,363,000 - 7,487,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
7.87 (5.69 - 11) 2019 Modelled IHME
8.03 (5.78 - 10.90) 2018 Modelled IHME
8.15 (5.94 - 11) 2017 Modelled IHME
8.13 (6 - 10.90) 2016 Modelled IHME
8.16 (5.96 - 11) 2015 Modelled IHME
8.24 (6.09 - 11.10) 2014 Modelled IHME
8.27 (5.99 - 11.10) 2013 Modelled IHME
8.25 (6.07 - 11) 2012 Modelled IHME
8.31 (6.19 - 10.90) 2011 Modelled IHME
8.4 (6.24 - 11) 2010 Modelled IHME
8.47 (6.35 - 11.10) 2009 Modelled IHME
8.53 (6.63 - 11.20) 2008 Modelled IHME
8.59 (6.60 - 11.10) 2007 Modelled IHME
8.7 (6.68 - 11.10) 2006 Modelled IHME
8.82 (6.81 - 11.30) 2005 Modelled IHME
8.96 (7 - 11.60) 2004 Modelled IHME
9.11 (7.08 - 11.60) 2003 Modelled IHME
9.27 (7.18 - 12) 2002 Modelled IHME
9.38 (7.23 - 12.10) 2001 Modelled IHME
9.45 (7.22 - 12.40) 2000 Modelled IHME
9.48 (7.18 - 12.50) 1999 Modelled IHME
9.6 (7.17 - 12.90) 1998 Modelled IHME
9.78 (7.28 - 13.10) 1997 Modelled IHME
9.89 (7.14 - 13.50) 1996 Modelled IHME
9.96 (7.09 - 13.90) 1995 Modelled IHME
9.91 (6.88 - 14.10) 1994 Modelled IHME
9.92 (6.73 - 14.40) 1993 Modelled IHME
9.99 (6.61 - 14.70) 1992 Modelled IHME
10 (6.50 - 14.90) 1991 Modelled IHME
10.1 (6.43 - 15.20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
17,644 (12,752 - 24,554) 2019 Modelled IHME
17,606 (12,684 - 23,927) 2018 Modelled IHME
17,502 (12,769 - 23,584) 2017 Modelled IHME
17,094 (12,617 - 22,890) 2016 Modelled IHME
16,793 (12,256 - 22,683) 2015 Modelled IHME
16,569 (12,252 - 22,347) 2014 Modelled IHME
16,252 (11,766 - 21,883) 2013 Modelled IHME
15,845 (11,655 - 21,185) 2012 Modelled IHME
15,579 (11,600 - 20,467) 2011 Modelled IHME
15,371 (11,414 - 20,171) 2010 Modelled IHME
15,122 (11,335 - 19,790) 2009 Modelled IHME
14,862 (11,539 - 19,580) 2008 Modelled IHME
14,579 (11,208 - 18,799) 2007 Modelled IHME
14,395 (11,063 - 18,452) 2006 Modelled IHME
14,232 (10,984 - 18,192) 2005 Modelled IHME
14,098 (11,009 - 18,265) 2004 Modelled IHME
13,975 (10,856 - 17,735) 2003 Modelled IHME
13,861 (10,739 - 17,926) 2002 Modelled IHME
13,671 (10,545 - 17,661) 2001 Modelled IHME
13,440 (10,269 - 17,568) 2000 Modelled IHME
13,148 (9,955 - 17,386) 1999 Modelled IHME
12,993 (9,708 - 17,473) 1998 Modelled IHME
12,925 (9,625 - 17,267) 1997 Modelled IHME
12,775 (9,227 - 17,400) 1996 Modelled IHME
12,572 (8,953 - 17,585) 1995 Modelled IHME
12,227 (8,487 - 17,376) 1994 Modelled IHME
11,973 (8,126 - 17,396) 1993 Modelled IHME
11,786 (7,806 - 17,382) 1992 Modelled IHME
11,566 (7,503 - 17,243) 1991 Modelled IHME
11,379 (7,256 - 17,165) 1990 Modelled IHME
12,122 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
50 (44 - 54) 2019 Modelled IHME
50 (45 - 55) 2018 Modelled IHME
50 (44 - 54) 2017 Modelled IHME
49 (44 - 54) 2016 Modelled IHME
49 (44 - 54) 2015 Modelled IHME
49 (44 - 54) 2014 Modelled IHME
49 (44 - 54) 2013 Modelled IHME
50 (44 - 54) 2012 Modelled IHME
50 (45 - 54) 2011 Modelled IHME
50 (45 - 54) 2010 Modelled IHME
50 (45 - 54) 2009 Modelled IHME
50 (45 - 54) 2008 Modelled IHME
50 (45 - 55) 2007 Modelled IHME
50 (45 - 55) 2006 Modelled IHME
50 (45 - 55) 2005 Modelled IHME
50 (45 - 55) 2004 Modelled IHME
51 (45 - 55) 2003 Modelled IHME
51 (46 - 56) 2002 Modelled IHME
51 (46 - 56) 2001 Modelled IHME
51 (46 - 56) 2000 Modelled IHME
51 (46 - 56) 1999 Modelled IHME
52 (46 - 56) 1998 Modelled IHME
52 (47 - 57) 1997 Modelled IHME
52 (47 - 57) 1996 Modelled IHME
52 (47 - 57) 1995 Modelled IHME
52 (47 - 57) 1994 Modelled IHME
52 (47 - 57) 1993 Modelled IHME
53 (47 - 57) 1992 Modelled IHME
53 (47 - 58) 1991 Modelled IHME
53 (47 - 58) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
18 (16 - 21) 2015 Survey/reported Pakistan National AIDS Control Program, 2015
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2015 Survey/reported NACP, 2015.

Number of persons treated for HCV

National
Download
Value Year Type Source
65,000 2015 Survey/reported WHO, 2018
161,000 2016 Survey/reported WHO, 2018
Showing out of
Show more
Technical notes

Number of 28-pill count bottles exported from Indian manufacturers (SOF-based regimens)

National
Download
Value Year Type Source
73,386 2016 Survey/reported CHAI HCV Market Report
100,002 2017 Survey/reported CHAI HCV Market Report
104,504 2018 Survey/reported CHAI HCV Market Report
68,661 2019 Survey/reported CHAI HCV Market Report
Showing out of
Show more
Technical notes

Price of HCV cure (Lowest average FOB price for 3 months of pangenotypic regimens)

National
Download
Value (US $) Year Type Source
231 2016 Survey/reported CHAI HCV Market Report
84 2017 Survey/reported CHAI HCV Market Report
60 2018 Survey/reported CHAI HCV Market Report
75 2019 Survey/reported CHAI HCV Market Report
Showing out of
Show more
Technical notes
HBV National Action Plan
Source:
HBV elimination goal
Source:
Year of HBV elimination goal
2030
Source:
HBV testing policy
Pregnant women
Source:
HepB birth dose policy
Yes
Source:
Eligible for HBV generic medicines
Source: MPP
Year of birth dose introduction
2016
Source: WHO
HCV National Action Plan
Source:
HCV elimination goal
Source:
Year of HCV elimination goal
2030
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)
Source: WHO

Overview

HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2030

Prevalence (national)

Modelled

HBV (HBsAg+)
2.3 (%)
2019
(2.04 - 2.61(%))
IHME
HCV (RNA/cAg+)
1.68 (%)
2019
(1.34 - 2.09(%))
IHME

Survey/surveillance

HBV (HBsAg+)
2.5 (%)
2010
Qureshi et al, 2010
HCV (anti-HCV)
4.8 (%)
2010
Qureshi et al, 2010

Hepatitis related deaths (national)

Modelled

HBV
16,208
2019
(11,878 - 21,656)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
17,644
2019
(12,752 - 24,554)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.54 (%)
2019, latest modelled
(0.43 - 0.68(%))
IHME

Prevalence PWID

HCV
36.50 (%)
2013, latest modelled
(0 - 79.10(%))
Degenhardt L et al, 2017

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
18
2015
(16 - 21)
Pakistan National AIDS Control Program, 2015
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Latest news

View all

Action plan

View all
health education
teaching students
teaching a small group
Previous Next

News

Action plans

Resources